Siebert, S., Coates, L., Schett, G., Raychaudhuri, S., Chen, W., Gao, S., . . . Deodhar, A. (2024). Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley.
Chicago Style (17th ed.) CitationSiebert, S., et al. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley, 2024.
MLA引文Siebert, S., et al. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley, 2024.
警告：這些引文格式不一定是100％准確.